John P. Mullooly, PhD

home / authors / john-p-mullooly-phd

Articles

Site Logo
October 1st 2005

Improving Services for Sex Partners of Chlamydia-infected Patients in an HMO

John P. Mullooly, PhD Barbara Valanis, RN, DrPH Julie E. Maher, PhD Nancy A. Vuckovic, PhD Jerry Slepack, MD Susan G. Cooksey, PhD Kathy Easter, BS Nancy H. Stevens, PhD Kathleen Irwin, MD, MP

Site Logo
October 1st 2004

Secondary Prevention of Domestic Violence in HMO Primary Care: Evaluation of Alternative Implementation Strategies

Diana Shye, PhD, MPH Virginia Feldman, MD Carolyn S. Hokanson, MD John P. Mullooly, PhD

Site Logo
November 1st 2002

Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors

Diana Shye, PhD, MPH Jonathan B. Brown, MPP, PhD John P. Mullooly, PhD Gregory A. Nichols, PhD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
ICYMI: Highlights From IMS 2024
Published: December 17th 2024 | Updated: December 21st 2024
ICYMI: Highlights From IMS 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo